VANCOUVER, BRITISH COLUMBIA--(Marketwire - February 07, 2008) - Forbes Medi-Tech Inc. (TSX: FMI)(NASDAQ: FMTI) today announced its revenue guidance for its sterol based business. The Company anticipates 2008 sales of $9.75 - $10.5 million, an increase of up to 20% compared to the range given for 2007 of $8.75 to $9.25 million. The revenue guidance is primarily based on the contracted and forecasted tonnage of Reducol™, and other value added products for sale into the functional food and dietary supplement markets.
